Participation in three consecutive mass drug administrations in Leogane, Haiti

Tropical Medicine and International Health

Volumn 11, Issue 6, 2006, Pages 862-868

  Mathieu, Els ^a   Direny, Abdel N ^b   De Rochars, Madsen Beau ^b   Streit, Thomas G ^c   Addiss, David G ^a   Lammie, Patrick J ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b Hôpital Ste Croix ^*  (Haïti)

^c UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Community based distribution; Eradication; Lymphatic filariasis; Survey

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; IVERMECTIN;

DISEASE TREATMENT; DRUG; FILARIASIS; LOCAL PARTICIPATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FILARIASIS; GENDER; HAITI; HEALTH EDUCATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; RURAL AREA; SIDE EFFECT; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTHELMINTICS; CHILD; CHILD, PRESCHOOL; ELEPHANTIASIS, FILARIAL; FEMALE; HAITI; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFANT; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; POPULATION SURVEILLANCE; RURAL HEALTH; SOCIOECONOMIC FACTORS; URBAN HEALTH;

ATLANTIC ISLANDS; ATLANTIC OCEAN; CARIBBEAN ISLANDS; GREATER ANTILLES; HAITI;

EID: 33744932215     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2006.01626.x     Document Type: Article

References (12)

1. Andre FE 2003 Vaccinology: past achievements, present roadblocks and future promises. Vaccine 21, 593 595.
2. Bieler GS 2001 SUDAAN Basics. Research Triangle Institute, Research Triangle Park, NC.
3. Biritwum RB Sylla M Diarra T et al. 1997 Evaluation of invermectin distribution in Benin, Cote d'Ivoire, Ghana and Togo: estimation of coverage of treatment and operational aspects of the distribution system. Annals of Tropical Medicine and Parasitology 91, 297 305.
4. Mathieu E Deming M Lammie P et al. 2003 Comparison of Methods for Estimating Drug Coverage for Filariasis Elimination, Leogane, Haiti. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 567 569.
5. Mathieu E Lammie PJ Radday J et al. 2004 Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti. Annals of Tropical Medicine and Parasitology 98, 703 714.
6. Anon. Morbidity & Mortality Weekly Reports 1993 Recommendations of the International Task Force for Disease Eradication. 42, (RR16) 1 25.
7. Ottesen EA Duke BO Karam M Behbehani K 1997 Strategies and tools for the control/elimination of lymphatic filariasis. Bulletin of the World Health Organization 75, 491 503.
8. Ottesen EA Ismail MM Horton J 1999 The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitology Today 15, 382 386.
9. Stolk WA Swaminathan S van Oortmarssen GJ Das PK Habbema JD 2003 Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. Journal of Infectious Diseases 188, 1371 1381.
10. Anon. 2001 Lymphatic filariasis. Weekly Epidemiological Record 76, 149 156.
11. WHO 1991 Training for Mid-level Managers, WHO/EPI/MLM/91.10.
12. World Health Report 1995 Bridging the Gaps. WHO, Geneva.